News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Cdk Inhibitors
September 1, 2025
Treatment of Early Stage Breast Cancers
Charles H. Weaver, MD
August 29, 2025
Side Effects and New CDK Inhibitor Class of Breast Cancer Drugs
Charles H. Weaver, MD
August 27, 2025
Endocrine – Hormone Therapy for Early Stage Breast Cancer
Charles H. Weaver, MD
September 17, 2024
Targeted Therapies Show Promise in Early Phase Trials
Charles H. Weaver, MD
April 29, 2024
Endocrine-Hormone Therapy for Advanced-Metastatic Breast Cancer
Charles H. Weaver, MD
February 4, 2023
Trodelvy for HR+/HER2– Metastatic Breast Cancer
Charles H. Weaver, MD
December 12, 2020
Kisqali Improves Survival in Women with ER+ Advanced Breast Cancer
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
